Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07633418 · ClinicalTrials.gov registry record · Phase 4
IO Vancomycin Administration in TKA
A Phase 4 study, sponsored by University of California, San Diego.
- Not yet
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT07633418 is a Phase 4 study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 30 participants.
The verdict
NCT07633418, a Phase 4 study, has not yet begun recruiting, sponsored by University of California, San Diego.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a prospective, single-center, open-label study evaluating systemic vancomycin levels following preoperative intraosseous administration in patients undergoing primary unilateral total knee arthroplasty. Eligible participants will receive preoperative intraosseous vancomycin (500 mg in 100 mL saline) as part of standard perioperative infection prophylaxis. The study is open-label due to the nature of the intervention. Blood samples will be collected at predefined time points intraoperatively to measure serum vancomycin concentrations. Patients will be randomized to either a tourniquet or no tourniquet for these blood draws.
Interventions
- DRUG Intraosseous Vamcomycin Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-04-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07633418
The ClinicalTrials.gov registry entry for NCT07633418 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intraosseous Vamcomycin Administration is the first listed.
NCT07633418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07633418 about?
NCT07633418 is a clinical study titled "IO Vancomycin Administration in TKA". This is a prospective, single-center, open-label study evaluating systemic vancomycin levels following preoperative intraosseous administration in patients undergoing primary unilateral total knee arthroplasty. Eligible participants will receive preoperative intraosseous vancomycin (500 mg in 100 mL...
What is the current status of trial NCT07633418?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2026-06-01. Estimated completion is 2029-04-29.
What interventions are being tested in trial NCT07633418?
The interventions under investigation include: Intraosseous Vamcomycin Administration (DRUG).
Who is sponsoring clinical trial NCT07633418?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.